Ulrich Abildgaard

Professor emeritus - Kreftklinikken
Bilde av Ulrich Abildgaard
English version of this page
Telefon +47 22894974
Besøksadresse OUS Rikshospitalet Forskningsveien 2 A 0372 Oslo
Postadresse OUS, Rikshospitalet Postboks 4950 Nydalen 0424 Oslo


  • Navarro-Fernandez, Jose; de la Morena-Barrio, Maria Eugenia; Martinez-Alonso, Emma; Dybedal, Ingunn; Toderici, Mara; Bohdan, Nataliya; Minano, Antonia; Heimdal, Ketil Riddervold; Abildgaard, Ulrich; Martinez-Menarguez, Jose Angel; Corral, Javier & Vicente, Vicente (2018). Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family. OncoTarget.  ISSN 1949-2553.  9(69), s 33202- 33214 . doi: 10.18632/oncotarget.26059 Vis sammendrag
  • Abildgaard, Ulrich & Heimdal, Ketil Riddervold (2013). Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. European Journal of Obstetrics, Gynecology, and Reproductive Biology.  ISSN 0301-2115.  166(2), s 117- 123 . doi: 10.1016/j.ejogrb.2012.09.026
  • Andresen, Marianne Seierstad; Sandven, Irene; Brunborg, Cathrine; Johansen, Anne Mette; Strekerud, Finn; Abdelnoor, Michael; Smith, Pål & Abildgaard, Ulrich (2011). Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy. Thrombosis Research.  ISSN 0049-3848.  127(6), s 540- 546 . doi: 10.1016/j.thromres.2011.02.017
  • Abildgaard, Ulrich; Sandset, Per Morten; Hammerstrøm, Jens; Gjestvang, Finn Tore & Tveit, Arnljot (2009). Management of pregnant women with mechanical heart valve prosthesis: Thromboprophylaxis with Low molecular weight heparin. Thrombosis Research.  ISSN 0049-3848.  124(3), s 262- 267 . doi: 10.1016/j.thromres.2008.12.005
  • Andresen, Marianne Seierstad; Eilertsen, Anette Løken; Abildgaard, Ulrich & Sandset, Per Morten (2007). Hormone therapy and raloxifene reduce the coagulation inhibitor potential. Blood Coagulation and Fibrinolysis.  ISSN 0957-5235.  18, s 455- 460 Vis sammendrag
  • Brosstad, Frank; Abildgaard, Ulrich; Breivik, Harald & Sellevold, Olav F Münter (2007). Marevan og blodplatehemmere ved kirurgi. Tidsskrift for Den norske legeforening.  ISSN 0029-2001. Vis sammendrag
  • Jacobsen, EM; Trettenes, EJ; Wisløff, Finn Georg B & Abildgaard, Ulrich (2006). Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene. Thrombosis Journal.  ISSN 1477-9560.  4, s 3- 8
  • Andresen, Marianne S; Abildgaard, Ulrich; Liestøl, Sigurd; Sandset, Per Morten; Mowinckel, M.C.; Ødegaard, Ole Rasmus; Larsen, ML. & Diep, Lien (2004). The ability of three global plasma assays to recognize thrombophilia. Thrombosis Research.  ISSN 0049-3848.  113(6), s 411- 7 Vis sammendrag
  • Sandset, Per Morten & Abildgaard, Ulrich (2004). Tissue factor pathway inhibitor revisited. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  2(12), s 2242- 2243
  • Iversen, Nina; Lindahl, Anne Karin & Abildgaard, Ulrich (2002). Elevated plasma Levels of the factor Xa-TFPI complex in cancer patients. Thrombosis Research.  ISSN 0049-3848.  105(1), s 33- 36 . doi: 10.1016/S0049-3848(01)00404-2
  • Boffa, Marie-Claire; Lapeyrere, C; Berard, M; Lindahl, Anne Karin; Flageul, B; Chemaly, P; Abildgaard, Ulrich & Dubertret, L (1994). Plasma thrombomodulin Level in malignancy varies according to the tumor type. La Nouvelle revue francaise.  ISSN 0029-4802.
  • Abildgaard, Ulrich; Sandset, Per Morten & Lindahl, Anne Karin (1993). Tissue Factor Pathway Inhibitor, In L Poller (ed.),  Recent Advances in Blood Coagulation 6.  Churchill Livingstone.  ISBN 978-0443047558.  I.
  • Lindahl, Anne Karin; Boffa, Marie-Claire & Abildgaard, Ulrich (1993). Increased plasma thrombomodulin in cancer patients. Thrombosis and Haemostasis.  ISSN 0340-6245.
  • Lindahl, Anne Karin; Boffa, Marie-Claire & Abildgaard, Ulrich (1993). Tissue factor pathway inhibitor. Thrombosis and Haemostasis.  ISSN 0340-6245.
  • Kristensen, HI; Østergaard, PB; Nordfang, O; Abildgaard, Ulrich & Lindahl, Anne Karin (1992). Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin. Thrombosis and Haemostasis.  ISSN 0340-6245.
  • Lindahl, Anne Karin; Sandset, Per Morten & Abildgaard, Ulrich (1992). The present status of tissue factor pathway inhibitor. Blood Coagulation and Fibrinolysis.  ISSN 0957-5235.
  • Abildgaard, Ulrich; Lindahl, Anne Karin & Sandset, Per Morten (1991). Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood. Thrombosis and Haemostasis.  ISSN 0340-6245.
  • Lindahl, Anne Karin; Abildgaard, Ulrich; Larsen, ML; Aamodt, LM; Nordfang, O & Beck, TC (1991). Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation. Thrombosis Research.  ISSN 0049-3848.
  • Lindahl, Anne Karin; Abildgaard, Ulrich; Larsen, ML; Staalesen, R; Hammer, AK; Sandset, PM; Nordfang, O & Beck, TC (1991). Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI. Thrombosis Research.  ISSN 0049-3848.
  • Lindahl, Anne Karin; Abildgaard, Ulrich & Staalesen, R (1991). The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor. Thrombosis Research.  ISSN 0049-3848.
  • Lindahl, Anne Karin; Jacobsen, PB; Sandset, Per Morten & Abildgaard, Ulrich (1991). Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagulation and Fibrinolysis.  ISSN 0957-5235.
  • Norrheim, L; Abildgaard, Ulrich; Larsen, ML & Lindahl, Anne Karin (1991). Involvement of the extrinsic pathway in the activities of low molecular weight heparins. Thrombosis Research.  ISSN 0049-3848.
  • Sandset, Per Morten; Larsen, ML; Abildgaard, Ulrich; Lindahl, Anne Karin & Ødegaard, OR (1991). Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels in the normal population and relation to cholesterol. Blood Coagulation and Fibrinolysis.  ISSN 0957-5235.
  • Lindahl, Anne Karin; Abildgaard, Ulrich & Stokke, G (1990). Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients. Thrombosis Research.  ISSN 0049-3848.
  • Lindahl, Anne Karin; Sandset, Per Morten & Abildgaard, Ulrich (1990). Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction. Thrombosis and Haemostasis.  ISSN 0340-6245.
  • Lindahl, Anne Karin; Sandset, Per Morten; Abildgaard, Ulrich; Andersson, TR & Harbitz, Thorstein Backe (1989). High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer. Acta Chiropterologica.  ISSN 1508-1109.

Se alle arbeider i Cristin

  • Toth, Orsolya; Conard, Jacqueline; Losonczy, Hajna; Reger, Barbara; Andresen, Marianne Seierstad; Horellou, Marie-Helene; Mozes, Reka & Abildgaard, Ulrich (2012). High sensitivity of the global CIP assay for hereditary thrombophilia. Thrombosis Research.  ISSN 0049-3848.  130, s S133- S133 . doi: 10.1016/j.thromres.2012.08.085

Se alle arbeider i Cristin

Publisert 29. juni 2020 15:12 - Sist endret 29. juni 2020 15:12